Overview

Opioid-Free Shoulder Arthroplasty

Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
Purpose of Study: To identify and provide a safe, opioid-free treatment pathway for shoulder arthroplasty with a focus on perioperative pain control and postoperative symptoms from treatment
Phase:
Phase 4
Details
Lead Sponsor:
OrthoCarolina Research Institute, Inc.
Treatments:
Acetaminophen
Analgesics, Opioid
Celecoxib
Desflurane
Gabapentin
Ketorolac
Ketorolac Tromethamine
Lidocaine
Propofol
Rocuronium
Sevoflurane
Vecuronium Bromide